Clinical Trials Browser

SCLC, Extensive Stage × Carboplatin × Clear all

NCT06477523 2024-06-27

Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC

Phase 1/2 Recruiting

SCLC, Extensive Stage

NCT05116007 2024-05-31

Anti-PD-1 and VEGF Bispecific Antibody AK112 in Combination With Chemotherapy in Patients With ES-SCLC

Phase 1 Completed

SCLC, Extensive Stage